Overview

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Status:
Completed
Trial end date:
2024-01-22
Target enrollment:
Participant gender:
Summary
A study to evaluate impact of Obicetrapib on PK levels of Atorvastatin and Rosuvastatin
Phase:
Phase 1
Details
Lead Sponsor:
NewAmsterdam Pharma
Collaborator:
Pharma Medica Research, Inc.
Treatments:
Atorvastatin
Calcium
Calcium, Dietary
Rosuvastatin Calcium